HOLX vs INVA · P/E 32, rev $4.10B vs P/E 3.6, rev $217.6M
Hologic Inc (HOLX) versus Innoviva Inc (INVA) — a side-by-side from cached financials, not a winner call.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Innoviva Inc (INVA) is a biotechnology company listed on US.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Latest reported INVA revenue for 2026-06-30 was $217.6M. Net income was $103.2M. INVA currently screens at market cap $1.66B and trailing P/E 3.6.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. INVA currently screens at market cap $1.66B and trailing P/E 3.6.
Not investment advice. Open the HOLX and INVA stock pages for the full models.
Not investment advice.